Interleukin-8 neutralization for COPD.
Ken-ichiro
K
Inoue
Hirohisa
H
Takano
Rie
R
Yanagisawa
Toshikazu
T
Yoshikawa
D000280:Administration, Inhalation; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology; D061067:Antibodies, Monoclonal, Humanized; D004305:Dose-Response Relationship, Drug; D004417:Dyspnea / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D016209:Interleukin-8 / Q000276:immunology*; D018375:Neutrophil Activation / Q000187:drug effects; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy* / Q000276:immunology; D023062:Receptors, Interleukin-8A / Q000037:antagonists & inhibitors*; D012129:Respiratory Function Tests
C492798:ABX-Interleukin 8; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D016209:Interleukin-8; D023062:Receptors, Interleukin-8A